Tailored Resistance Training After Adverse Pregnancy Outcomes

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Approximately 7-10 postpartum people with recent adverse pregnancy outcomes (APOs: preeclampsia, gestational diabetes, hypertensive disorders of pregnancy, fetal growth restriction or low birth weight baby, or preterm birth) will be invited to complete 4 weeks of a resistance training intervention, including associated incentives, communication, and marketing materials.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 45
Healthy Volunteers: f
View:

• Had a single baby in your most recent pregnancy

• Are 18-45 years old

• Are 3-15 months postpartum

• Are not currently pregnant

• Had an adverse pregnancy outcome/medical complication in your most recent pregnancy, including preeclampsia, gestational diabetes, hypertensive disorders of pregnancy, fetal growth restriction or low birth weight baby, or preterm birth

• Your doctor told you that you are able to participate in exercise

• Are not currently meeting national physical activity guidelines, defined as 150 min/wk of aerobic exercise and 2 resistance training sessions/wk

• Can attend a visit at the University of Michigan's School of Kinesiology Building

• Are willing to perform resistance exercise twice a week for 4 weeks

• Are willing to receive and respond to a daily message sharing whether you completed resistance exercise that day and completed it as recommended

Locations
United States
Michigan
School of Kinesiology
RECRUITING
Ann Arbor
Contact Information
Primary
Abbi Lane, PhD
abbilane@umich.edu
734-647-3843
Backup
Marnie McLean, MS
abbilane@umich.edu
734-936-1387
Time Frame
Start Date: 2026-01-08
Estimated Completion Date: 2026-05
Participants
Target number of participants: 10
Treatments
Experimental: Intervention
Resistance training
Sponsors
Leads: University of Michigan
Collaborators: Women's Health Innovation Fund

This content was sourced from clinicaltrials.gov